Additionally, flow cytometry analysis revealed a significant reduction in colon cancer cell death upon ATXN3 ablation, with Galectin-9 expression reversing the apoptosis of ATXN3-null colon cancer cells (Fig. 4, G and H). This evidence concerns the gene ATXN3 and colonic neoplasm.